Casa
ralf morales ojo

Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development

Por um escritor misterioso

Descrição
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Recombinant NMT myristoylates a Leishmania substrate protein in E.
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
PDF) Structure-Guided Identification of Resistance Breaking Antimalarial N‑ Myristoyltransferase Inhibitors
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
NMT1 and NMT2 have lysine transferase activity and can modify ARF6 on
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness. - Abstract - Europe PMC
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Contacts between SC-58272 and Nmt1p.a, Contact distances (Å). The
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum. - Abstract - Europe PMC
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Discovery of a Novel Class of Orally Active Trypanocidal N- Myristoyltransferase Inhibitors
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Cryptosporidiosis Drug Discovery: Opportunities and Challenges
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Prioritization of Molecular Targets for Antimalarial Drug Discovery
Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
de por adulto (o preço varia de acordo com o tamanho do grupo)